Psychological Co-morbidities of Cardiovascular Disease

  • Matthew C. Whited
  • Amanda L. Wheat
  • Bradley M. Appelhans
  • Sherry Pagoto
Chapter

Abstract

Cardiovascular disease (CVD) is the leading cause of death in the U.S. and other developed nations. Because CVD often cooccurs with various mental disorders, healthcare providers responsible for either physical or mental health should be aware of how these conditions influence each other and the implications for treatment. This chapter reviews the prevalence and pathophysiology of the associations between CVD and mental disorders, reviews the literature on assessment, treatment, clinical considerations, and makes recommendations for areas in need of further research.

Keywords

Placebo Cholesterol Obesity Nicotine Serotonin 

References

  1. Abbas, C. C., Schmid, J. P., Guler, E., Wiedemar, L., Begre, S., Saner, H., et al. (2009). Trajectory of posttraumatic stress disorder caused by myocardial infarction: A two-year follow-up study. International Journal of Psychiatry in Medicine, 39(4), 359–376.PubMedGoogle Scholar
  2. Agelink, M. W., Boz, C., Ullrich, H., & Andrich, J. (2002). Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Research, 113(1–2), 139–149.PubMedGoogle Scholar
  3. Aina, Y., & Susman, J. L. (2006). Understanding comorbidity with depression and anxiety disorders. Journal of the American Osteopathic Association, 106(Suppl 2), S9–S14.PubMedGoogle Scholar
  4. Amani, R. (2007). Is dietary pattern of schizophrenia patients different from healthy subjects? BMC Psychiatry, 7, 15.PubMedGoogle Scholar
  5. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists & North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27(2), 596–601.Google Scholar
  6. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders. Washington: American Psychiatric Association.Google Scholar
  7. Anda, R. F., Williamson, D. F., Escobedo, L. G., Mast, E. E., Giovino, G. A., & Remington, P. L. (1990). Depression and the dynamics of smoking – A national perspective. Journal of the American Medical Association, 264(12), 1541–1545.PubMedGoogle Scholar
  8. Angst, F., Stassen, H. H., Clayton, P. J., & Angst, J. (2002). Mortality of patients with mood disorders: Follow-up over 34–38 years. Journal of Affective Disorders, 68(2–3), 167–181.PubMedGoogle Scholar
  9. Bankier, B., Januzzi, J. L., & Littman, A. B. (2004). The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosomatic Medicine, 66(5), 645–650.PubMedGoogle Scholar
  10. Bansal, B., Khan, M., & Salhan, A. K. (2009). A review of measurement and analysis of heart rate variability. International conference on computer and automation engineering, 8–10 March, pp. 243–246.Google Scholar
  11. Bar, K. J., Boettger, M. K., Koschke, M., Schulz, S., Chokka, P., Yeragani, V. K., et al. (2007). Non-linear complexity measures of heart rate variability in acute schizophrenia. Clinical Neurophysiology, 118(9), 2009–2015.PubMedGoogle Scholar
  12. Bar, K. J., Greiner, W., Jochum, T., Friedrich, M., Wagner, G., & Sauer, H. (2004). The influence of major depression and its treatment on heart rate variability and pupillary light reflex parameters. Journal of Affective Disorders, 82(2), 245–252.PubMedGoogle Scholar
  13. Bar, K. J., Koschke, M., Boettger, M. K., Berger, S., Kabisch, A., Sauer, H., et al. (2007). Acute psychosis leads to increased QT variability in patients suffering from schizophrenia. Schizophrenia Research, 95(1–3), 115–123.PubMedGoogle Scholar
  14. Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004). Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosomatic Medicine, 66(6), 802–813.PubMedGoogle Scholar
  15. Bastien, D. L. (2010). Pharmacological treatment of combat-induced PTSD: A literature review. British Journal of Nursing (Mark Allen Publishing), 19(5), 318–321.Google Scholar
  16. Baune, B. T., Adrian, I., Arolt, V., & Berger, K. (2006). Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population. Psychotherapy and Psychosomatics, 75(5), 319–326.PubMedGoogle Scholar
  17. Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897.PubMedGoogle Scholar
  18. Bell, R. C., Farmer, S., Ries, R., & Srebnik, D. (2009). Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics. Psychiatric Services, 60(12), 1686–1689.PubMedGoogle Scholar
  19. Berg, A., Lonnqvist, J., Palomaki, H., & Kaste, M. (2009). Assessment of depression after stroke a comparison of different screening instruments. Stroke, 40(2), 523–529.PubMedGoogle Scholar
  20. Berkman, L. F., Blumenthal, J., Burg, M., Carney, R. M., Catellier, D., Cowan, M. J., et al. (2003). Effects of treating depression and low-perceived social support on clinical events after myocardial infarction – The enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. Journal of the American Medical Association, 289(23), 3106–3116.PubMedGoogle Scholar
  21. Berntson, G. G., Bigger, J. T., Eckberg, D. L., Grossman, P., Kaufmann, P. G., Malik, M., et al. (1997). Heart rate variability: Origins, methods, and interpretive caveats. Psychophysiology, 34(6), 623–648.PubMedGoogle Scholar
  22. Bhogal, S. K., Teasell, R., Foley, N., & Speechley, M. (2004). Lesion location and poststroke depression – Systematic review of the methodological limitations in the literature. Stroke, 35(3), 794–802.PubMedGoogle Scholar
  23. Bigger, J. T., Fleiss, J. L., Rolnitzky, L. M., & Steinman, R. C. (1993). The ability of several short-term measures of RR variability to predict mortality after myocardial-infarction. Circulation, 88(3), 927–934.PubMedGoogle Scholar
  24. Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the hospital anxiety and depression scale – An updated literature review. Journal of Psychosomatic Research, 52(2), 69–77.PubMedGoogle Scholar
  25. Blasco-Fontecilla, H., Baca-Garcia, E., & de Leon, J. (2010). Do atypical antipsychotic drugs reduce the risk of ischemic heart disease and mortality? Possible role of 5-HT2A receptor blockade. Schizophrenia Research, 119(1–3), 160–163.PubMedGoogle Scholar
  26. Bonnet, F., Irving, K., Terra, J. L., Nony, P., Berthezene, F., & Moulin, P. (2005). Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis, 178(2), 339–344.PubMedGoogle Scholar
  27. Bradford, D. W., Kim, M. M., Braxton, L. E., Marx, C. E., Butterfield, M., & Elbogen, E. B. (2008). Access to medical care among persons with psychotic and major affective disorders. Psychiatric Services, 59(8), 847–852.PubMedGoogle Scholar
  28. Brar, J. S., Ganguli, R., Pandina, G., Turkoz, I., Berry, S., & Mahmoud, R. (2005). Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. The Journal of Clinical Psychiatry, 66(2), 205–212.PubMedGoogle Scholar
  29. Bresee, L. C., Majumdar, S. R., Patten, S. B., & Johnson, J. A. (2010). Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study. Schizophrenia Research, 117(1), 75–82.PubMedGoogle Scholar
  30. Bruce, E. C., & Musselman, D. L. (2005). Depression, alterations in platelet function, and ischemic heart disease. Psychosomatic Medicine, 67, S34–S36.PubMedGoogle Scholar
  31. Callaghan, R. C., Boire, M. D., Lazo, R. G., McKenzie, K., & Cohn, T. (2009). Schizophrenia and the incidence of cardiovascular morbidity: A population-based longitudinal study in Ontario, Canada. Schizophrenia Research, 115(2–3), 325–332.PubMedGoogle Scholar
  32. Capasso, R. M., Lineberry, T. W., Bostwick, J. M., Decker, P. A., & Sauver, J. S. (2008). Mortality in schizophrenia and schizoaffective disorder: An Olmsted county, Minnesota cohort: 1950–2005. Schizophrenia Research, 98(1–3), 287–294.PubMedGoogle Scholar
  33. Carney, R. M., Blumenthal, J. A., Freedland, K. E., Stein, P. K., Howells, W. B., Berkman, L. F., et al. (2005). Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Archives of Internal Medicine, 165(13), 1486–1491.PubMedGoogle Scholar
  34. Carney, R. M., & Freedland, K. E. (2008). Depression in patients with coronary heart disease. The American Journal of Medicine, 121(11 Suppl 2), S20–S27.PubMedGoogle Scholar
  35. Carney, R. M., & Freedland, K. E. (2009). Depression and heart rate variability in patients with coronary heart disease. Cleveland Clinic Journal of Medicine, 76(Suppl 2), S13–S17.PubMedGoogle Scholar
  36. Carney, R. M., Freedland, K. E., & Jaffe, A. S. (2009). Depression screening in patients with heart disease. Journal of the American Medical Association, 301(13), 1337.PubMedGoogle Scholar
  37. Carrizo, E., Fernandez, V., Quintero, J., Connell, L., Rodriguez, Z., Mosquera, M., et al. (2008). Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives. Schizophrenia Research, 103(1–3), 83–93.PubMedGoogle Scholar
  38. Chambless, D. L., & Ollendick, T. H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685–716.PubMedGoogle Scholar
  39. Chang, H. H., Yang, Y. K., Gean, P. W., Huang, H. C., Chen, P. S., & Lu, R. B. (2010). The role of valproate in metabolic disturbances in bipolar disorder patients. Journal of Affective Disorders, 124(3), 319–323.PubMedGoogle Scholar
  40. Chen, C. K., Chen, Y. C., & Huang, Y. S. (2009). Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: A 12-month follow up. Psychiatry and Clinical Neurosciences, 63(1), 17–22.PubMedGoogle Scholar
  41. Chen, Y. H., Hu, C. J., Lee, H. C., & Lin, H. C. (2010). An Increased risk of stroke among panic disorder patients: A 3-year follow-up study. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 55(1), 43–49.PubMedGoogle Scholar
  42. Cohen, H. W., Gibson, G., & Alderman, M. H. (2000). Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. The American Journal of Medicine, 108(1), 2–8.PubMedGoogle Scholar
  43. Daughters, S. B., Braun, A. R., Sargeant, M. N., Reynolds, E. K., Hopko, D. R., Blanco, C., et al. (2008). Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: The life enhancement treatment for substance use (LETS Act!). The Journal of Clinical Psychiatry, 69(1), 122–129.PubMedGoogle Scholar
  44. Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., et al. (2008). Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophrenia Research, 105(1–3), 175–187.PubMedGoogle Scholar
  45. Daumit, G. L., Goldberg, R. W., Anthony, C., Dickerson, F., Brown, C. H., Kreyenbuhl, J., et al. (2005). Physical activity patterns in adults with severe mental illness. The Journal of Nervous and Mental Disease, 193(10), 641–646.PubMedGoogle Scholar
  46. Davidson, K. W., Kupfer, D. J., Bigger, J. T., Califf, R. M., Carney, R. M., Coyne, J. C., et al. (2006). Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report. Psychosomatic Medicine, 68(5), 645–650.PubMedGoogle Scholar
  47. Davidson, K. W., Rieckmann, N., Clemow, L., Schwartz, J. E., Shimbo, D., Medina, V., et al. (2010). Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms coronary psychosocial evaluation studies randomized controlled trial. Archives of Internal Medicine, 170(7), 600–608.PubMedGoogle Scholar
  48. Davies, S. J. C., Jackson, P. R., Potokar, J., & Nutt, D. J. (2004). Treatment of anxiety and depressive disorders in patients with cardiovascular disease. British Medical Journal, 328(7445), 939–943.PubMedGoogle Scholar
  49. De Hert, M., Kalnicka, D., van Winkel, R., Wampers, M., Hanssens, L., Van Eyck, D., et al. (2006). Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder. The Journal of Clinical Psychiatry, 67(12), 1889–1896.PubMedGoogle Scholar
  50. de Jonge, P., Honig, A., van Melle, J. P., Schene, A. H., Kuyper, A. M. G., Tulner, D., et al. (2007). Nonresponse to treatment for depression following myocardial infarction: Association with subsequent cardiac events. The American Journal of Psychiatry, 164(9), 1371–1378.PubMedGoogle Scholar
  51. De Leon, J., & Diaz, F. J. (2007). Planning for the optimal design of studies to personalize antipsychotic prescriptions in the post-CATIE era: The clinical and pharmacoepidemiological data suggest that pursuing the pharmacogenetics of metabolic syndrome complications (hypertension, diabetes mellitus and hyperlipidemia) may be a reasonable strategy. Schizophrenia Research, 96(1–3), 185–197.PubMedGoogle Scholar
  52. Deacon, B. J., & Abramowitz, J. S. (2004). Cognitive and behavioral treatments for anxiety disorders: A review of meta-analytic findings. Journal of Clinical Psychology, 60(4), 429–441.PubMedGoogle Scholar
  53. Dedert, E., Calhoun, P., Watkins, L., Sherwood, A., & Beckham, J. (2010). Posttraumatic stress disorder, cardiovascular, and metabolic disease: A review of the evidence. Annals of Behavioral Medicine, 39(1), 61–78.PubMedGoogle Scholar
  54. Dell’Osso, B., Buoli, M., Baldwin, D. S., & Altamura, A. C. (2010). Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: A comprehensive review of their clinical efficacy. Human Psychopharmacology-Clinical and Experimental, 25(1), 17–29.PubMedGoogle Scholar
  55. Diaz, F. J., James, D., Botts, S., Maw, L., Susce, M. T., & de Leon, J. (2009). Tobacco smoking behaviors in bipolar disorder: A comparison of the general population, schizophrenia, and major depression. Bipolar Disorders, 11(2), 154–165.PubMedGoogle Scholar
  56. Diaz, F. J., Meary, A., Arranz, M. J., Ruano, G., Windemuth, A., & de Leon, J. (2009). Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels. Schizophrenia Research, 115(2–3), 136–140.PubMedGoogle Scholar
  57. Dimidjian, S., & Davis, K. J. (2009). Newer variations of cognitive-behavioral therapy: Behavioral activation and mindfulness-based cognitive therapy. Current Psychiatry Reports, 11, 453–458.PubMedGoogle Scholar
  58. Druss, B. G., Bradford, W. D., Rosenheck, R. A., Radford, M. J., & Krumholz, H. M. (2001). Quality of medical care and excess mortality in older patients with mental disorders. Archives of General Psychiatry, 58(6), 565–572.PubMedGoogle Scholar
  59. Eze-Nliam, C. M., Thombs, B. D., Lima, B. B., Smith, C. G., & Ziegelstein, R. C. (2010). The association of depression with adherence to antihypertensive medications: A systematic review. Journal of Hypertension, 28(9), 1785–1795.PubMedGoogle Scholar
  60. Fan, A. Z., Strine, T. W., Jiles, R., & Mokdad, A. H. (2008). Depression and anxiety associated with cardiovascular disease among persons aged 45 years and older in 38 states of the United States. Preventive Medicine, 46(5), 445–450.PubMedGoogle Scholar
  61. Fang, J., & Cheng, Q. (2009). Etiological mechanisms of post-stroke depression: A review. Neurological Research, 31(9), 904–909.PubMedGoogle Scholar
  62. Felker, B., Yazel, J. J., & Short, D. (1996). Mortality and medical comorbidity among psychiatric patients: A review. Psychiatric Services, 47(12), 1356–1363.PubMedGoogle Scholar
  63. Fiedorowicz, J. G., Solomon, D. A., Endicott, J., Leon, A. C., Li, C. S., Rice, J. P., et al. (2009). Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosomatic Medicine, 71(6), 598–606.PubMedGoogle Scholar
  64. Fleet, R., Lavoie, K., & Beitman, B. D. (2000). Is panic disorder associated with coronary artery disease? A critical review of the literature. Journal of Psychosomatic Research, 48(4–5), 347–356.PubMedGoogle Scholar
  65. Flegal, K. M., Carroll, M. D., & Ogden, C. L. (2010). Prevalence and trends in obesity among US Adults, 1999–2008. Journal of the American Medical Association, 303(3), 235–241.PubMedGoogle Scholar
  66. Ford, E. S., Giles, W. H., & Dietz, W. H. (2002). Prevalence of the metabolic syndrome among US adults: Findings from the third national Health and Nutrition Examination Survey. Journal of the American Medical Association, 287, 356–359.PubMedGoogle Scholar
  67. Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., et al. (2010). Antidepressant drug effects and depression severity a patient-level meta-analysis. Journal of the American Medical Association, 303(1), 47–53.PubMedGoogle Scholar
  68. Frasure-Smith, N., & Lesperance, F. (2010). Depression and cardiac risk: Present status and future directions. Heart, 96(3), 173–176.PubMedGoogle Scholar
  69. Garcia-Portilla, M. P., Saiz, P. A., Bascaran, M. T., Martinez, S., Benabarre, A., Sierra, P., et al. (2009). Cardiovascular risk in patients with bipolar disorder. Journal of Affective Disorders, 115(3), 302–308.PubMedGoogle Scholar
  70. Glassman, A. H., Bigger, J. T., Gaffney, M., Shapiro, P. A., & Swenson, J. R. (2006). Onset of major depression associated with acute coronary syndromes – Relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Archives of General Psychiatry, 63(3), 283–288.PubMedGoogle Scholar
  71. Glassman, A. H., O’Connor, C. M., Califf, R. M., Swedberg, K., Schwartz, P., Bigger, J. T., et al. (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association, 288(6), 701–709.PubMedGoogle Scholar
  72. Gleason, P. P., Schulz, R., Smith, N. L., Newsom, J. T., Kroboth, P., Kroboth, F. J., et al. (1998). Correlates and prevalence of benzodiazepine use in community-dwelling elderly. Journal of General Internal Medicine, 13(4), 243–250.PubMedGoogle Scholar
  73. Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., et al. (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 80(1), 45–53.PubMedGoogle Scholar
  74. Goldstein, B. I., Fagiolini, A., Houck, P., & Kupfer, D. J. (2009). Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disorders, 11(6), 657–662.PubMedGoogle Scholar
  75. Goodwin, R. D., Davidson, K. W., & Keyes, K. (2009). Mental disorders and cardiovascular disease among adults in the United States. Journal of Psychiatric Research, 43(3), 239–246.PubMedGoogle Scholar
  76. Grippo, A. J. (2009). Mechanisms underlying altered mood and cardiovascular dysfunction: The value of neurobiological and behavioral research with animal models. Neuroscience and Biobehavioral Reviews, 33(2), 171–180.PubMedGoogle Scholar
  77. Guler, E., Schmid, J. P., Wiedemar, L., Saner, H., Schnyder, U., & von Kanel, R. (2009). Clinical diagnosis of posttraumatic stress disorder after myocardial infarction. Clinical Cardiology, 32(3), 125–129.PubMedGoogle Scholar
  78. Gulliksson, M., Burell, G., Vessby, B., Lundin, L., Toss, H., & Svardsudd, K. (2011). Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care Project (SUPRIM). Archives of Internal Medicine, 171(2), 134–140.PubMedGoogle Scholar
  79. Hackett, M. L., Anderson, C. S., House, A., & Xia, J. (2008). Interventions for treating depression after stroke. Cochrane Database of Systematic Reviews (4), CD003437.Google Scholar
  80. Hambridge, J. A., Turner, A., & Baker, A. L. (2009). BraveHeart begins: Pilot results of group cognitive behaviour therapy for depression and anxiety in cardiac patients. The Australian and New Zealand Journal of Psychiatry, 43(12), 1171–1177.PubMedGoogle Scholar
  81. Hari, R., Begre, S., Schmid, J. P., Saner, H., Gander, M. L., & von Kanel, R. (2010). Change over time in posttraumatic stress caused by myocardial infarction and predicting variables. Journal of Psychosomatic Research, 69(2), 143–150.PubMedGoogle Scholar
  82. Harter, M., Woll, S., Wunsch, A., Bengel, J., & Reuter, K. (2006). Screening for mental disorders in cancer, cardiovascular, and musculoskeletal diseases. Social Psychiatry and Psychiatric Epidemiology, 41, 56–62.PubMedGoogle Scholar
  83. Haupt, D. W., Rosenblatt, L. C., Kim, E., Baker, R. A., Whitehead, R., & Newcomer, J. W. (2009). Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. The American Journal of Psychiatry, 166(3), 345–353.PubMedGoogle Scholar
  84. Hennekens, C. H. (2007). Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. The Journal of Clinical Psychiatry, 68(Suppl 4), 4–7.PubMedGoogle Scholar
  85. Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal, 150(6), 1115–1121.PubMedGoogle Scholar
  86. Herrmann, C. (1997). International experiences with the hospital anxiety and depression scale – A review of validation data and clinical results. Journal of Psychosomatic Research, 42, 17–41.PubMedGoogle Scholar
  87. Herrmann, C., Brand-Driehorst, S., Buss, U., & Rüger, U. (2000). Effects of anxiety and depression on 5-year mortality in 5057 patients referred for exercise testing. Journal of Psychosomatic Research, 48(4–5), 455–462.PubMedGoogle Scholar
  88. Hippisley-Cox, J., Parker, C., Coupland, C., & Vinogradova, Y. (2007). Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: A cross-sectional study. Heart, 93(10), 1256–1262.PubMedGoogle Scholar
  89. Hippisley-Cox, J., Pringle, M., Hammersley, V., Crown, N., Wynn, A., Meal, A., et al. (2001). Antidepressants as risk factor for ischaemic heart disease: Case-control study in primary care. British Medical Journal, 323(7314), 666–669.PubMedGoogle Scholar
  90. Hirschfeld, R. M. A., Williams, J. B. W., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., et al. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: The mood disorder questionnaire. The American Journal of Psychiatry, 157(11), 1873–1875.PubMedGoogle Scholar
  91. Hoffman, E. J., & Mathew, S. J. (2008). Anxiety disorders: A comprehensive review of pharmacotherapies. The Mount Sinai Journal of Medicine, 75(3), 248–262.Google Scholar
  92. Hopko, D. R., Lejuez, C. W., & Hopko, S. D. (2008). Cognitive-behavior therapy for depressed cancer patients in a medical care setting. Behavior Therapy, 39, 126–136.PubMedGoogle Scholar
  93. Hopko, D. R., Lejuez, C. W., LePage, J. P., Hopko, S. D., & McNeil, D. W. (2003). A brief behavioral activation treatment for depression: A randomized trial within an inpatient psychiatric hospital. Behavior Modification, 27, 458–469.PubMedGoogle Scholar
  94. Huffman, J. C., & Stern, T. A. (2003). The use of benzodiazepines in the treatment of chest pain: A review of the literature. The Journal of Emergency Medicine, 25(4), 427–437.PubMedGoogle Scholar
  95. Ibishi, N. F., Musliu, N. R., Kamberi, A., Qirko, S., Brokaj, S., Lezha, M., et al. (2009). Impact of depression and cardiovascular disease. Psychiatric Annals, 39(1), 22–25.Google Scholar
  96. Jacka, F. N., Pasco, J. A., Mykletun, A., Williams, L. J., Hodge, A. M., O’Reilly, S. L., et al. (2010). Association of Western and traditional diets with depression and anxiety in women. The American Journal of Psychiatry, 167(3), 305–311.PubMedGoogle Scholar
  97. Janeway, D. (2009). An Integrated approach to the diagnosis and treatment of anxiety within the practice of cardiology. Cardiology in Review, 17(1), 36–43.PubMedGoogle Scholar
  98. Janszky, I., Ahnve, S., Lundberg, I., & Hemmingsson, T. (2010). Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. Journal of the American College of Cardiology, 56(1), 31–37.PubMedGoogle Scholar
  99. Jindal, R., MacKenzie, E. M., Baker, G. B., & Yeragani, V. K. (2005). Cardiac risk and schizophrenia. Journal of Psychiatry & Neuroscience, 30(6), 393–395.Google Scholar
  100. Joynt, K. E., & O’Connor, C. M. (2005). Lessons from SADHART, ENRICHD, and other trials. Psychosomatic Medicine, 67, S63–S66.PubMedGoogle Scholar
  101. Kemp, A. H., Quintana, D. S., Gray, M. A., Felmingham, K. L., Brown, K., & Gatt, J. M. (2010). Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biological Psychiatry, 67(11), 1067–1074.PubMedGoogle Scholar
  102. Kent, L. K., & Shapiro, P. A. (2009). Depression and related psychological factors in heart disease. Harvard Review of Psychiatry, 17(6), 377–388.PubMedGoogle Scholar
  103. Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627.PubMedGoogle Scholar
  104. Ketter, T. A. (2010). Strategies for monitoring outcomes in patients with bipolar disorder. The Primary Care Companion to the Journal of Clinical Psychiatry, 12(Suppl 1), 10–16.Google Scholar
  105. Kilbourne, A. M., Post, E. P., Nossek, A., Drill, L., Cooley, S., & Bauer, M. S. (2008). Improving medical and psychiatric outcomes among individuals with bipolar disorder: A randomized controlled trial. Psychiatric Services, 59(7), 760–768.PubMedGoogle Scholar
  106. Kilbourne, A. M., Post, E. P., Nossek, A., Sonel, E., Drill, L. J., Cooley, S., et al. (2008). Service delivery in older patients with bipolar disorder: A review and development of a medical care model. Bipolar Disorders, 10(6), 672–683.PubMedGoogle Scholar
  107. Kilbourne, A. M., Rofey, D. L., McCarthy, J. F., Post, E. P., Welsh, D., & Blow, F. C. (2007). Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disorders, 9(5), 443–452.PubMedGoogle Scholar
  108. Kim, J. Y., & Lee, H. W. (2007). Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy. Epilepsia, 48(7), 1366–1370.PubMedGoogle Scholar
  109. Kop, W. J., & Gottdiener, J. S. (2005). The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosomatic Medicine, 67, S37–S41.PubMedGoogle Scholar
  110. Koponen, H., Jokelainen, J., Keinanen-Kiukaanniemi, S., Kumpusalo, E., & Vanhala, M. (2008). Metabolic syndrome predisposes to depressive symptoms: A population-based 7-year follow-up study. The Journal of Clinical Psychiatry, 69(2), 178–182.PubMedGoogle Scholar
  111. Koschke, M., Boettger, M. K., Schulz, S., Berger, S., Terhaar, J., Voss, A., et al. (2009). Autonomy of autonomic dysfunction in major depression. Psychosomatic Medicine, 71(8), 852–860.PubMedGoogle Scholar
  112. Krantz, D. S., Whittaker, K. S., Francis, J. L., Rutledge, T., Johnson, B. D., Barrow, G., et al. (2009). Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: Outcomes from the Women’s Ischemia Syndrome Evaluation (WISE) study. Heart, 95(23), 1901–1906.PubMedGoogle Scholar
  113. Kreyenbuhl, J., Dickerson, F. B., Medoff, D. R., Brown, C. H., Goldberg, R. W., Fang, L., et al. (2006). Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. The Journal of Nervous and Mental Disease, 194(6), 404–410.PubMedGoogle Scholar
  114. Kronish, I. M., Rieckmann, N., Halm, E. A., Shimbo, D., Vorchheimer, D., Haas, D. C., et al. (2006). Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. Journal of General Internal Medicine, 21(11), 1178–1183.PubMedGoogle Scholar
  115. Kronish, I. M., Rieckmann, N., Schwartz, J. E., Schwartz, D. R., & Davidson, K. W. (2009). Is depression after an acute coronary syndrome simply a marker of known prognostic factors for mortality? Psychosomatic Medicine, 71(7), 697–703.PubMedGoogle Scholar
  116. Kubzansky, L. D., Koenen, K. C., Jones, C., & Eaton, W. W. (2009). A prospective study of posttraumatic stress disorder symptoms and coronary heart disease in women. Health Psychology, 28(1), 125–130.PubMedGoogle Scholar
  117. Kubzansky, L. D., Koenen, K. C., Spiro, A., Vokonas, P. S., & Sparrow, D. (2007). Prospective study of posttraumatic stress disorder symptoms and coronary heart disease in the normative aging study. Archives of General Psychiatry, 64, 110–116.Google Scholar
  118. Kuczmarski, M. F., Sees, A. C., Hotchkiss, L., Cotugna, N., Evans, M. K., & Zonderman, A. B. (2010). Higher healthy eating index-2005 scores associated with reduced symptoms of depression in an urban population: Findings from the Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS) study. Journal of the American Dietetic Association, 110(3), 383–389.PubMedGoogle Scholar
  119. Kuijpers, P., Hamulyak, K., Strik, J., Wellens, H. J. J., & Honig, A. (2002). Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression. Psychiatry Research, 109(2), 207–210.PubMedGoogle Scholar
  120. Kwon, J. S., Choi, J. S., Bahk, W. M., Yoon Kim, C., Hyung Kim, C., Chul Shin, Y., et al. (2006). Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. The Journal of Clinical Psychiatry, 67(4), 547–553.PubMedGoogle Scholar
  121. Lesperance, F., Frasure-Smith, N., Koszycki, D., Laliberte, M. A., van Zyl, L. T., Baker, B., et al. (2007). Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease – The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. Journal of the American Medical Association, 297(4), 367–379.PubMedGoogle Scholar
  122. Licht, C. M. M., De Geus, E. J. C., Van Dyck, R., & Penninx, B. W. J. H. (2010). Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biological Psychiatry, 68(9), 861–868.PubMedGoogle Scholar
  123. Licht, C. M. M., de Geus, E. J. C., Zitman, F. G., Hoogendijk, W. J. G., van Dyck, R., & Penninx, B. W. J. H. (2008). Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Archives of General Psychiatry, 65(12), 1358–1367.PubMedGoogle Scholar
  124. Lincoln, N. B., & Flannaghan, T. (2003). Cognitive behavioral psychotherapy for depression following stroke – A randomized controlled trial. Stroke, 34(1), 111–115.PubMedGoogle Scholar
  125. Lindamer, L. A., McKibbin, C., Nonnan, G. J., Jordan, L., Harrison, K., Abeyesinhe, S., et al. (2008). Assessment of physical activity in middle-aged and older adults with schizophrenia. Schizophrenia Research, 104(1–3), 294–301.PubMedGoogle Scholar
  126. Lindenmayer, J. P., Khan, A., Wance, D., Maccabee, N., Kaushik, S., & Kaushik, S. (2009). Outcome evaluation of a structured educational wellness program in patients with severe mental illness. The Journal of Clinical Psychiatry, 70(10), 1385–1396.PubMedGoogle Scholar
  127. Ljubic, M. A., Deane, F. P., Zecchin, R. P., & Denniss, R. (2006). Motivation, psychological distress, and exercise adherence following myocardial infarction. Australian Journal of Rehabilitation Counseling, 12(1), 21–32.Google Scholar
  128. Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., et al. (1996). Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation, 93(5), 1043–1065.Google Scholar
  129. Markovitz, J. H., Matthews, K. A., Wing, R. R., Kuller, L. H., & Meilahn, E. N. (1991). Psychological, biological and health behavior predictors of blood pressure changes in middle-aged women. Journal of Hypertension, 9(5), 399–406.PubMedGoogle Scholar
  130. Martens, E. J., de Jonge, P., Na, B., Cohen, B. E., Lett, H., & Whooley, M. A. (2010). Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease the heart and soul study. Archives of General Psychiatry, 67(7), 750–758.PubMedGoogle Scholar
  131. McConnell, S., Jacka, F. N., Williams, L. J., Dodd, S., & Berk, M. (2005). The relationship between depression and cardiovascular disease. International Journal of Psychiatry in Clinical Practice, 9(3), 157–167.Google Scholar
  132. McConnell, S. D., Inderbitzin, L. B., & Pollard, W. E. (1992). Primary health care in the CMHC: A role for the nurse practitioner. Hospital and Community Psychiatry, 43(7), 724–727.PubMedGoogle Scholar
  133. McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., et al. (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research, 80(1), 19–32.PubMedGoogle Scholar
  134. McIntosh, A., Cohen, A., Turnbull, N., Esmonde, L., Dennis, P., Eatock, J., et al. (2004). Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder. Sheffield: National Collaborating Centre for Primary Care.Google Scholar
  135. McKibbin, C. L., Patterson, T. L., Norman, G., Patrick, K., Jin, H., Roesch, S., et al. (2006). A lifestyle intervention for older schizophrenia patients with diabetes mellitus: A randomized controlled trial. Schizophrenia Research, 86(1–3), 36–44.PubMedGoogle Scholar
  136. McManus, D., Pipkin, S. S., & Whooley, M. A. (2005). Screening for depression in patients with coronary heart disease (data from the heart and soul study). The American Journal of Cardiology, 96(8), 1076–1081.PubMedGoogle Scholar
  137. Meyer, J. M., Davis, V. G., Goff, D. C., McEvoy, J. P., Nasrallah, H. A., Davis, S. M., et al. (2008). Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1. Schizophrenia Research, 101(1–3), 273–286.PubMedGoogle Scholar
  138. Meyer, J. M., & Koro, C. E. (2004). The effects of antipsychotic therapy on serum lipids: A comprehensive review. Schizophrenia Research, 70(1), 1–17.PubMedGoogle Scholar
  139. Meyer, T., Buss, U., & Herrmann-Lingen, C. (2010). Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosomatic Medicine, 72(1), 9–15.PubMedGoogle Scholar
  140. Mitchell, P. H., Veith, R. C., Becker, K. J., Buzaitis, A., Cain, K. C., Fruin, M., et al. (2009). Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant living well with stroke: Randomized, controlled trial. Stroke, 40(9), 3073–3078.PubMedGoogle Scholar
  141. Morrato, E. H., Newcomer, J. W., Kamat, S., Baser, O., Harnett, J., & Cuffel, B. (2009). Metabolic screening after the American diabetes association’s consensus statement on antipsychotic drugs and diabetes. Diabetes Care, 32(6), 1037–1042.PubMedGoogle Scholar
  142. Murray, D. P., Weiner, M., Prabhakar, M., & Fiedorowicz, J. G. (2009). Mania and mortality: Why the excess cardiovascular risk in bipolar disorder? Current Psychiatry Reports, 11(6), 475–480.PubMedGoogle Scholar
  143. Mykletun, A., Bjerkeset, O., Dewey, M., Prince, M., Overland, S., & Stewart, R. (2007). Anxiety, depression, and cause-specific mortality: The HUNT study. Psychosomatic Medicine, 69(4), 323–331.PubMedGoogle Scholar
  144. Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Davis, S. M., Stroup, T. S., et al. (2006). Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research, 86(1–3), 15–22.PubMedGoogle Scholar
  145. Newcomer, J. W. (2009). Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses. The Journal of Clinical Psychiatry, 70, 30–36.PubMedGoogle Scholar
  146. Newcomer, J. W., & Haupt, D. W. (2006). The metabolic effects of antipsychotic medications. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 51(8), 480–491.PubMedGoogle Scholar
  147. Norton, P. J., & Price, E. C. (2007). A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. The Journal of Nervous and Mental Disease, 195(6), 521–531.PubMedGoogle Scholar
  148. O’Connor, C. M., Jiang, W., Kuchibhatla, M., Silva, S. G., Cuffe, M. S., Callwood, D. D., et al. (2010). Safety and efficacy of sertraline for depression in patients with heart failure. Journal of the American College of Cardiology, 56(9), 692–699.PubMedGoogle Scholar
  149. Olafiranye, O., Jean-Louis, G., Magai, C., Zizi, F., Brown, C. D., Dweck, M., et al. (2010). Anxiety and cardiovascular symptoms: The modulating role of insomnia. Cardiology, 115(2), 114–119.PubMedGoogle Scholar
  150. Olfson, M., Fireman, B., Weissman, M., Leon, A. C., Sheehan, D. V., Kathol, R. G., et al. (1997). Mental disorders and disability among patients in a primary care group practice. The American Journal of Psychiatry, 154(12), 1734–1740.PubMedGoogle Scholar
  151. Osborn, D. P., Nazareth, I., & King, M. B. (2007). Physical activity, dietary habits and coronary heart disease risk factor knowledge amongst people with severe mental illness: A cross sectional comparative study in primary care. Social Psychiatry and Psychiatric Epidemiology, 42(10), 787–793.PubMedGoogle Scholar
  152. Ozeki, Y., Fujii, K., Kurimoto, N., Yamada, N., Okawa, M., Aoki, T., et al. (2010). QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(2), 401–405.Google Scholar
  153. Peter, H., Goebel, P., Müller, S., & Hand, I. (1999). Clinically relevant cholesterol elevation in anxiety disorders: A comparison with normal controls. International Journal of Behavioral Medicine, 6(1), 30–39.PubMedGoogle Scholar
  154. Pollock, B. G., Laghrissi-Thode, F., & Wagner, W. R. (2000). Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology, 20(2), 137–140.PubMedGoogle Scholar
  155. Potokar, J. P., & Nutt, D. J. (2000). Chest pain: Panic attack or heart attack? International Journal of Clinical Practice, 54(2), 110–114.PubMedGoogle Scholar
  156. Pozuelo, L., Zhang, J. P., Franco, K., Tesar, G., Penn, M., & Jiang, W. (2009). Depression and heart disease: What do we know, and where are we headed? Cleveland Clinic Journal of Medicine, 76(1), 59–70.PubMedGoogle Scholar
  157. Qureshi, S. U., Pyne, J. M., Magruder, K. M., Schulz, P. E., & Kunik, M. E. (2009). The link between post-traumatic stress disorder and physical comorbidities: A systematic review. Psychiatry Quarterly, 80, 87–97.Google Scholar
  158. Rafanelli, C., Milaneschi, Y., Roncuzzi, R., & Pancaldi, L. G. (2010). Dysthymia before myocardial infarction as a cardiac risk factor at 2.5-year follow-up. Psychosomatics, 51(1), 8–13.PubMedGoogle Scholar
  159. Rieckmann, N., Gerin, W., Kronish, I. M., Burg, M. M., Chaplin, W. F., Kong, G., et al. (2006). Course of depressive symptoms and medication adherence after acute coronary syndromes – An electronic medication monitoring study. Journal of the American College of Cardiology, 48(11), 2218–2222.PubMedGoogle Scholar
  160. Rieckmann, N., Kronish, I. M., Haas, D., Gerin, W., Chaplin, W. F., Burg, M. M., et al. (2006). Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. American Heart Journal, 152(5), 922–927.PubMedGoogle Scholar
  161. Roest, A. M., Martens, E. J., Denollet, J., & de Jonge, P. (2010). Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: A meta-analysis. Psychosomatic Medicine, 72(6), 563–569.PubMedGoogle Scholar
  162. Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J. G., Goodwin, R. D., Kubzansky, L., et al. (2008). Anxiety disorders and comorbid medical illness. General Hospital Psychiatry, 30(3), 208–225.PubMedGoogle Scholar
  163. Rozanski, A., & Kubzansky, L. D. (2005). Psychologic functioning and physical health: A paradigm of flexibility. Psychosomatic Medicine, 67, S47–S53.PubMedGoogle Scholar
  164. Rugulies, R. (2002). Depression as a predictor for coronary heart disease – A review and meta-analysis. American Journal of Preventive Medicine, 23(1), 51–61.PubMedGoogle Scholar
  165. Rutledge, T., Reis, V. A., Linke, S. E., Greenberg, B. H., & Mills, P. J. (2006). Depression in heart failure – A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. Journal of the American College of Cardiology, 48(8), 1527–1537.PubMedGoogle Scholar
  166. Sagen, U., Finset, A., Moum, T., Morland, T., Vik, T. G., Nagy, T., et al. (2010). Early detection of patients at risk for anxiety, depression and apathy after stroke. General Hospital Psychiatry, 32(1), 80–85.PubMedGoogle Scholar
  167. Sagen, U., Vik, T. G., Moum, T., Morland, T., Finset, A., & Dammen, T. (2009). Screening for anxiety and depression after stroke: Comparison of the Hospital Anxiety and Depression Scale and the Montgomery and Asberg Depression Rating Scale. Journal of Psychosomatic Research, 67(4), 325–332.PubMedGoogle Scholar
  168. Salaycik, K. J., Kelly-Hayes, M., Beiser, A., Nguyen, A. H., Brady, S. M., Kase, C. S., et al. (2007). Depressive symptoms and risk of stroke – The Framingham study. Stroke, 38(1), 16–21.PubMedGoogle Scholar
  169. Santos, M., Koevari, E., Gold, G., Bozikas, V. P., Hof, P. R., Bouras, C., et al. (2009). The neuroanatomical model of post-stroke depression: Towards a change of focus? Journal of the Neurological Sciences, 283(1–2, Sp. Iss. 1), 158–162.Google Scholar
  170. Schelling, G. (2007). Post-traumatic stress disorder in somatic disease: Lessons from critically ill patients. In E. R. DeKloet & E. Vermetten (Eds.), Stress hormones and post traumatic stress disorder: Basic studies and clinical perspectives (pp. 229–237). Amsterdam: Elsevier.Google Scholar
  171. Scherrer, J. F., Chrusciel, T., Zeringue, A., Garfield, L. D., Hauptman, P. J., Lustman, P. J., et al. (2010). Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed veterans administration patients. American Heart Journal, 159(5), 772–779.PubMedGoogle Scholar
  172. Scherrer, J. F., Xian, H., Bucholz, K. K., Eisen, S. A., Lyons, M. J., Goldberg, J., et al. (2003). A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosomatic Medicine, 65(4), 548–557.PubMedGoogle Scholar
  173. Scott, J. (2004). Pathophysiology and biochemistry of cardiovascular disease. Current Opinion in Genetics and Development, 14(3), 271–279.PubMedGoogle Scholar
  174. Serebruany, V. L., O’Connor, C. M., & Gurbel, P. A. (2001). Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. The American Journal of Cardiology, 87(12), 1398–1400.PubMedGoogle Scholar
  175. Sherbourne, C. D., Jackson, C. A., & Meredith, L. S. (1996). Prevalence of comorbid anxiety disorders in primary care outpatients. Archives of Family Medicine, 5(1), 27–34.PubMedGoogle Scholar
  176. Sigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.Google Scholar
  177. Skala, J. A., Freedland, K. E., & Carney, R. M. (2006). Coronary heart disease and depression: A review of recent mechanistic research. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 51(12), 738–745.PubMedGoogle Scholar
  178. Smoller, J. W., Allison, M., Cochrane, B. B., Curb, J. D., Perlis, R. H., Robinson, J. G., et al. (2009). Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Archives of Internal Medicine, 169(22), 2128–2139.PubMedGoogle Scholar
  179. Soh, K. C., & Lee, C. (2010). Panic attack and its correlation with acute coronary syndrome – More than just a diagnosis of exclusion. Annals of the Academy of Medicine, Singapore, 39(3), 197–202.PubMedGoogle Scholar
  180. Soreca, I., Frank, E., & Kupfer, D. J. (2009). The phenomenology of bipolar disorder: What drives the high rate of medical burden and determines long-term prognosis? Depression and Anxiety, 26(1), 73–82.PubMedGoogle Scholar
  181. Sowden, G. L., & Huffman, J. C. (2009). The impact of mental illness on cardiac outcomes: A review for the cardiologist. International Journal of Cardiology, 132(1), 30–37.PubMedGoogle Scholar
  182. Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E. (1970). Manual for the state-trait anxiety inventory. Paolo Alto: Consulting Psychologists Press.Google Scholar
  183. Spindler, H., & Pedersen, S. S. (2005). Posttraumatic stress disorder in the wake of heart disease: Prevalence, risk factors, and future research directions. Psychosomatic Medicine, 67(5), 715–723.PubMedGoogle Scholar
  184. Spitzer, C., Barnow, S., Volzke, H., John, U., Freyberger, H. J., & Grabe, H. J. (2009). Trauma, posttraumatic stress disorder, and physical illness: Findings from the general population. Psychosomatic Medicine, 71(9), 1012–1017.PubMedGoogle Scholar
  185. Stein, P. K., & Kleiger, R. E. (1999). Insights from the study of heart rate variability. Annual Review of Medicine, 50, 249–261.PubMedGoogle Scholar
  186. Stewart, J. C., Rand, K. L., Muldoon, M. F., & Kamarck, T. W. (2009). A prospective evaluation of the directionality of the depression-inflammation relationship. Brain, Behavior, and Immunity, 23(7), 936–944.PubMedGoogle Scholar
  187. Strine, T. W., Mokdad, A. H., Balluz, L. S., Gonzalez, O., Crider, R., Berry, J. T., et al. (2008). Depression and anxiety in the united states: Findings from the 2006 behavioral risk factor surveillance system. Psychiatric Services, 59(12), 1383–1390.PubMedGoogle Scholar
  188. Suls, J., & Bunde, J. (2005). Anger, anxiety, and depression as risk factors for cardiovascular disease: The problems and implications of overlapping affective dispositions. Psychological Bulletin, 131(2), 260–300.PubMedGoogle Scholar
  189. Swenson, J. R., Doucette, S., & Fergusson, D. (2006). Adverse cardiovascular events in antidepressant trials involving high-risk patients: A systematic review of randomized trials. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 51(14), 923–929.PubMedGoogle Scholar
  190. Teri, L., Logsdon, R. G., & McCurry, S. M. (2005). The Seattle protocols: Advances in behavioral treatment of Alzheimer’s disease. In M. Grundman, H. Feldman, L. J. Fitten, B. Winblad, & E. Giacobini (Eds.), Research and practice in Alzheimer’s disease (pp. 153–158). Paris: Serdi.Google Scholar
  191. Thayer, J. F., & Lane, R. D. (2007). The role of vagal function in the risk for cardiovascular disease and mortality. Biological Psychology, 74(2), 224–242.PubMedGoogle Scholar
  192. Thombs, B. D., de Jonge, P., Coyne, J. C., Whooley, M. A., Frasure-Smith, N., Mitchell, A. J., et al. (2008). Depression screening and patient outcomes in cardiovascular care a systematic review. Journal of the American Medical Association, 300(18), 2161–2171.PubMedGoogle Scholar
  193. Thorndike, A. N., Regan, S., McKool, K., Pasternak, R. C., Swartz, S., Torres-Finnerty, N., et al. (2008). Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Archives of Internal Medicine, 168(2), 186–191.PubMedGoogle Scholar
  194. Towle, D., Lincoln, N. B., & Mayfield, L. M. (1989). Evaluation of social work on depression after stroke. Clinical Rehabilitation, 3(2), 89–96.Google Scholar
  195. Vahia, I. V., Diwan, S., Bankole, A. O., Kehn, M., Nurhussein, M., Ramirez, P., et al. (2008). Adequacy of medical treatment among older persons with schizophrenia. Psychiatric Services, 59(8), 853–859.PubMedGoogle Scholar
  196. van Melle, J. P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G. P., Ormel, J., van Veldhuisen, D. J., et al. (2004). Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosomatic Medicine, 66(6), 814–822.PubMedGoogle Scholar
  197. Van Zyl, L. T., Hasegawa, T., & Nagata, K. (2008). Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review. BioPsychoSocial Medicine, 2, 12.PubMedGoogle Scholar
  198. Vogelzangs, N., Seldenrijk, A., Beekman, A. T. F., van Hout, H. P. J., de Jonge, P., & Penninx, B. (2010). Cardiovascular disease in persons with depressive and anxiety disorders. Journal of Affective Disorders, 125(1–3), 241–248.PubMedGoogle Scholar
  199. Watkins, C. L., Auton, M. F., Deans, C. F., Dickinson, H. A., Jack, C. I. A., Lightbody, C. E., et al. (2007). Motivational interviewing early after acute stroke – A randomized, controlled trial. Stroke, 38(3), 1004–1009.PubMedGoogle Scholar
  200. Wells, K. B., Golding, J. M., & Burnam, M. A. (1989). Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. General Hospital Psychiatry, 11(5), 320–327.PubMedGoogle Scholar
  201. White, K. S. (2008). Cardiovascular disease and anxiety. In M. J. Zvolensky & J. A. Smith (Eds.), Anxiety in health behaviors and physical illness (pp. 279–315). New York: Springer.Google Scholar
  202. Whooley, M. A., de Jonge, P., Vittinghoff, E., Otte, C., Moos, R., Carney, R. M., et al. (2008). Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. Journal of the American Medical Association, 300(20), 2379–2388.PubMedGoogle Scholar
  203. Williams, E. D., & Steptoe, A. (2007). The role of depression in the etiology of acute coronary syndrome. Current Psychiatry Reports, 9(6), 486–492.PubMedGoogle Scholar
  204. World Health Organization. (2007). International statistical classification of diseases and health-related problems: 10th revision, from http://apps.who.int/classifications/apps/icd/icd10online/. Retreived 2-1-11
  205. Wu, M. K., Wang, C. K., Bai, Y. M., Huang, C. Y., & Lee, S. D. (2007). Outcomes of obese, clozapine-treated in patients with schizophrenia placed on a six-month diet and physical activity program. Psychiatric Services, 58(4), 544–550.PubMedGoogle Scholar
  206. Wulsin, L. R., & Singal, B. M. (2003). Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine, 65(2), 201–210.PubMedGoogle Scholar
  207. Yilmaz, E., Dosan, Y., Gurgoze, M. K., & Gungor, S. (2001). Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children. Acta Neurologica Belgica, 101(4), 217–220.PubMedGoogle Scholar
  208. Zavoreo, I., Basic-Kes, V., Bosnar-Puretic, M., & Demarin, V. (2009). Post-stroke depression. Acta Clinica Croatica, 48(3), 329–333.PubMedGoogle Scholar
  209. Zhao, H. W., Zhou, C. X., Su, X. L., Xiao, X. C., & Guo, Y. (2004). Effect of a mental intervention on post-stroke depression and rehabilitation of neurological function. Chinese Journal of Clinical Rehabilitation, 8(13), 2408–2409.Google Scholar
  210. Ziedonis, D., Hitsman, B., Beckham, J., Zvolensky, M., Adler, L., Audrain-McGovern, J., et al. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research, 10(12), 1691–1715.Google Scholar
  211. Ziegelstein, R. C., Kim, S. Y., Kao, D., Fauerbach, J. A., Thombs, B. D., McCann, U., et al. (2005). Can doctors and nurses recognize depression in patients hospitalized with an acute myocardial infarction in the absence of formal screening? Psychosomatic Medicine, 67(3), 393–397.PubMedGoogle Scholar
  212. Zwanzger, P., Diemer, J., & Jabs, B. (2009). Comparison of combined psycho- and pharmacotherapy with monotherapy in anxiety disorders: Controversial viewpoints and clinical perspectives. Journal of Neural Transmission, 116(6), 759–765.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Matthew C. Whited
    • 1
  • Amanda L. Wheat
    • 2
  • Bradley M. Appelhans
    • 3
  • Sherry Pagoto
    • 4
  1. 1.Department of Medicine, Division of Preventive and Behavioral MedicineUniversity of Massachusetts Medical SchoolWorcesterUSA
  2. 2.Department of PsychologyWest Virginia UniversityMorgantownUSA
  3. 3.Departments of Preventive Medicine and Behavioral SciencesRush University Medical CenterChicagoUSA
  4. 4.University of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations